ASX - Delayed Quote AUD

Microba Life Sciences Limited (MAP.AX)

0.1900

+0.0050

+(2.70%)

At close: May 2 at 4:10:10 PM GMT+10

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

BRISBANE, Australia, April 29, 2025--Microba Life Sciences Limited (ASX: MAP) ("Microba") a precision microbiome company, today announces two significant developments: the release of new clinical utility results for its MetaPanel™ gastrointestinal pathogen test, and the signing of a strategic clinical partnership with the Colonoscopy Clinic, and its wholly owned partner, Integrated Gut Health, one of Australia’s leading gastroenterology services.

Business Wire 4 days ago

MAP.AX
+2.70%
3 ASX Penny Stocks With Market Caps Up To A$300M

The Australian share market is poised for a positive opening, with the ASX 200 expected to rise following a week marked by geopolitical developments and economic data releases. In such fluctuating conditions, investors often look beyond established giants to explore opportunities in smaller companies. Penny stocks, though an older term, remain relevant as they represent smaller or newer companies that can offer value and growth potential. This article will explore three penny stocks that...

Simply Wall St. 2 months ago

GHYLF

MAP.AX
+2.70%

SKS.AX
Spotlight On GreenX Metals And 2 Prominent ASX Penny Stocks

As the 2025 trading season begins, the Australian market is experiencing a mixed start, with the ASX 200 opening lower following global trends. Despite this cautious beginning, investors continue to seek opportunities in various sectors, including penny stocks—an area often overlooked but rich with potential. Although considered a somewhat outdated term, penny stocks still offer intriguing possibilities for growth when backed by strong financials and sound fundamentals.

Simply Wall St. 3 months ago

GRX.AX

MYE.AX

MAP.AX
+2.70%
ASX Penny Stocks To Monitor In December 2024

The ASX200 has recently climbed 0.67% to reach a record high of 8,504 points, buoyed by positive sentiment and a strong lead from Wall Street as the market enjoys the Santa rally. While traditional sectors like Discretionary and Financials are seeing gains, investors may also consider exploring opportunities in smaller or newer companies often referred to as penny stocks. Despite the term's outdated connotation, these stocks can offer significant growth potential when backed by solid...

Simply Wall St. 4 months ago

MAP.AX
+2.70%

SPD.AX

IGL.AX
Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long

Microba Life Sciences Limited ( ASX:MAP ) is possibly approaching a major achievement in its business, so we would like...

Simply Wall St. 6 months ago

MAP.AX
+2.70%
Microba Life Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Microba Life Sciences ( ASX:MAP ) Full Year 2024 Results Key Financial Results Revenue: AU$12.1m (up 123% from FY...

Simply Wall St. 7 months ago

MAP.AX
+2.70%

Performance Overview

Return	MAP.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	-2.56%	+0.97%
1-Year	+2.70%	+8.58%
3-Year	-45.59%	+12.13%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Microba Life Sciences Limited (MAP.AX)

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

3 ASX Penny Stocks With Market Caps Up To A$300M

Spotlight On GreenX Metals And 2 Prominent ASX Penny Stocks

ASX Penny Stocks To Monitor In December 2024

Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long

Microba Life Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Performance Overview